Development, Validation and Normative Data of the Italian Battery for the Recognition of Famous Faces (FAME)

Prior treatment

• History of previous stroke or multifocal stroke documented by imaging. Brainstem or cerebellar stroke. History of traumatic brain injury (TBI), seizures, brain tumors, neurodegenerative diseases, or psychiatric disorders.

Other illness

• Uncorrected vision or hearing impairment.
• Frontotemporal Dementia (FTD) Patients
• History of neurological diseases other than FTD (e.g., stroke, brain tumor, multiple sclerosis, traumatic brain injury).
• Uncorrected vision or hearing impairment. History of serious psychiatric diseases, developmental disorders (e.g., autism spectrum), or intellectual disability.
• Dementia severity (CDR) \> 1.
• Alzheimer's Disease (AD) Patients
• History of neurological diseases other than AD (e.g., stroke, brain tumor, multiple sclerosis, traumatic brain injury).
• Uncorrected vision or hearing impairment. History of serious psychiatric diseases, developmental disorders, or intellectual disability.
• Dementia severity (CDR) \> 1.
• Post-Stroke Patients

• Age 40-85 years. No chronic medical, neurological, or psychiatric conditions, or major depressive episode detected during screening.
• No history of schizophrenia or bipolar disorder in the 5 years prior to screening.
• Mini-Mental State Examination (MMSE) score ≥ 26.
• Diagnosis of probable FTD according to established clinical criteria. Age 40-85 years. Ability to provide informed consent.
• Diagnosis of probable AD according to established clinical criteria. Age 40-85 years. Ability to provide informed consent.
• Subacute phase: 1 week to 3 months post-event. Ischemic or hemorrhagic stroke confirmed by neuroimaging and/or clinical judgment.

Criteria the registry did not label

• Healthy Controls (HC)